SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-023097
Filing Date
2024-06-07
Accepted
2024-06-07 16:05:32
Documents
13
Period of Report
2024-06-05
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 65020
  Complete submission text file 0001493152-24-023097.txt   240555

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE dare-20240605.xsd EX-101.SCH 3033
3 XBRL LABEL FILE dare-20240605_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE dare-20240605_pre.xml EX-101.PRE 22371
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3661
Mailing Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122
Business Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122 858-926-7655
Dare Bioscience, Inc. (Filer) CIK: 0001401914 (see all company filings)

IRS No.: 204139823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36395 | Film No.: 241029308
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)